Cryo-Cell International, Inc. (AMEX: CCEL) Stock Competitors & Peer Comparison
See CCEL's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CCEL and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CCEL | $3.37 | -0.30% | 28.2M | -10.61 | -$0.33 | N/A |
| HCA | $408.18 | -2.39% | 90.6B | 14.10 | $28.96 | +0.74% |
| THC | $257.62 | -1.91% | 22.2B | 14.95 | $17.24 | N/A |
| DVA | $240.96 | +0.63% | 15.5B | 20.54 | $11.73 | N/A |
| SOLV | $88.55 | +2.76% | 15.3B | 14.19 | $6.24 | N/A |
| FMS | $24.86 | +0.44% | 13.4B | 9.87 | $2.52 | +3.47% |
| EHC | $113.80 | -1.92% | 11.3B | 20.00 | $5.69 | +0.67% |
| ENSG | $181.89 | -0.68% | 10.6B | 26.36 | $6.90 | +0.14% |
| UHS | $168.16 | +1.17% | 10.2B | 7.45 | $22.54 | +0.48% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
CCEL vs HCA Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, HCA has a market cap of 90.6B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while HCA trades at $408.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas HCA's P/E ratio is 14.10. In terms of profitability, CCEL's ROE is +0.14%, compared to HCA's ROE of -1.13%. Regarding short-term risk, CCEL is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
CCEL vs THC Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, THC has a market cap of 22.2B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while THC trades at $257.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas THC's P/E ratio is 14.95. In terms of profitability, CCEL's ROE is +0.14%, compared to THC's ROE of +0.51%. Regarding short-term risk, CCEL is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check THC's competition here
DaVita Inc. (NYSE: DVA)
CCEL vs DVA Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, DVA has a market cap of 15.5B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while DVA trades at $240.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas DVA's P/E ratio is 20.54. In terms of profitability, CCEL's ROE is +0.14%, compared to DVA's ROE of -1.33%. Regarding short-term risk, CCEL is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check DVA's competition here
Solventum Corporation (NYSE: SOLV)
CCEL vs SOLV Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, SOLV has a market cap of 15.3B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while SOLV trades at $88.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas SOLV's P/E ratio is 14.19. In terms of profitability, CCEL's ROE is +0.14%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, CCEL is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check SOLV's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
CCEL vs FMS Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, FMS has a market cap of 13.4B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while FMS trades at $24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas FMS's P/E ratio is 9.87. In terms of profitability, CCEL's ROE is +0.14%, compared to FMS's ROE of +0.07%. Regarding short-term risk, CCEL is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
CCEL vs EHC Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, EHC has a market cap of 11.3B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while EHC trades at $113.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas EHC's P/E ratio is 20.00. In terms of profitability, CCEL's ROE is +0.14%, compared to EHC's ROE of +0.25%. Regarding short-term risk, CCEL is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check EHC's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
CCEL vs ENSG Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while ENSG trades at $181.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas ENSG's P/E ratio is 26.36. In terms of profitability, CCEL's ROE is +0.14%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, CCEL is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
CCEL vs UHS Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, UHS has a market cap of 10.2B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while UHS trades at $168.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas UHS's P/E ratio is 7.45. In terms of profitability, CCEL's ROE is +0.14%, compared to UHS's ROE of +0.21%. Regarding short-term risk, CCEL is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
CCEL vs OSH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas OSH's P/E ratio is -17.65. In terms of profitability, CCEL's ROE is +0.14%, compared to OSH's ROE of +4.64%. Regarding short-term risk, CCEL is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
CCEL vs PACS Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while PACS trades at $46.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas PACS's P/E ratio is 39.49. In terms of profitability, CCEL's ROE is +0.14%, compared to PACS's ROE of +0.27%. Regarding short-term risk, CCEL is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
CCEL vs CHE Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, CHE has a market cap of 7.2B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while CHE trades at $539.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas CHE's P/E ratio is 24.99. In terms of profitability, CCEL's ROE is +0.14%, compared to CHE's ROE of +0.29%. Regarding short-term risk, CCEL is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
CCEL vs LHCG Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas LHCG's P/E ratio is 82.83. In terms of profitability, CCEL's ROE is +0.14%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, CCEL is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
CCEL vs LFST Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while LFST trades at $10.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas LFST's P/E ratio is 173.01. In terms of profitability, CCEL's ROE is +0.14%, compared to LFST's ROE of +0.02%. Regarding short-term risk, CCEL is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
CCEL vs CON Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, CON has a market cap of 4B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while CON trades at $31.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas CON's P/E ratio is 21.94. In terms of profitability, CCEL's ROE is +0.14%, compared to CON's ROE of +0.46%. Regarding short-term risk, CCEL is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
CCEL vs OPCH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, OPCH has a market cap of 3.8B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while OPCH trades at $23.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas OPCH's P/E ratio is 13.91. In terms of profitability, CCEL's ROE is +0.14%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, CCEL is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
CCEL vs NHC Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, NHC has a market cap of 3.6B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while NHC trades at $228.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas NHC's P/E ratio is 32.86. In terms of profitability, CCEL's ROE is +0.14%, compared to NHC's ROE of +0.12%. Regarding short-term risk, CCEL is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check NHC's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
CCEL vs BKD Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, BKD has a market cap of 3.5B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while BKD trades at $14.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas BKD's P/E ratio is -25.63. In terms of profitability, CCEL's ROE is +0.14%, compared to BKD's ROE of +401.19%. Regarding short-term risk, CCEL is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check BKD's competition here
Amedisys, Inc. (NASDAQ: AMED)
CCEL vs AMED Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AMED's P/E ratio is 39.30. In terms of profitability, CCEL's ROE is +0.14%, compared to AMED's ROE of +0.11%. Regarding short-term risk, CCEL is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
CCEL vs ACHC Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, ACHC has a market cap of 2.5B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while ACHC trades at $27.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas ACHC's P/E ratio is 13.74. In terms of profitability, CCEL's ROE is +0.14%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, CCEL is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check ACHC's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
CCEL vs ADUS Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while ADUS trades at $119.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas ADUS's P/E ratio is 18.50. In terms of profitability, CCEL's ROE is +0.14%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, CCEL is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
CCEL vs MD Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while MD trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas MD's P/E ratio is 12.49. In terms of profitability, CCEL's ROE is +0.14%, compared to MD's ROE of +0.20%. Regarding short-term risk, CCEL is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check MD's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
CCEL vs SGRY Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, SGRY has a market cap of 2.1B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while SGRY trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas SGRY's P/E ratio is 42.08. In terms of profitability, CCEL's ROE is +0.14%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, CCEL is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check SGRY's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
CCEL vs AVAH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AVAH trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AVAH's P/E ratio is 14.34. In terms of profitability, CCEL's ROE is +0.14%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, CCEL is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AVAH's competition here
Select Medical Holdings Corporation (NYSE: SEM)
CCEL vs SEM Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas SEM's P/E ratio is 15.43. In terms of profitability, CCEL's ROE is +0.14%, compared to SEM's ROE of +0.08%. Regarding short-term risk, CCEL is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check SEM's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
CCEL vs AMEH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AMEH's P/E ratio is 39.25. In terms of profitability, CCEL's ROE is +0.14%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, CCEL is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AMEH's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
CCEL vs ASTH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while ASTH trades at $36.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas ASTH's P/E ratio is 24.67. In terms of profitability, CCEL's ROE is +0.14%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, CCEL is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check ASTH's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
CCEL vs HCSG Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while HCSG trades at $23.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas HCSG's P/E ratio is 18.74. In terms of profitability, CCEL's ROE is +0.14%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, CCEL is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check HCSG's competition here
Ardent Health Inc. (NYSE: ARDT)
CCEL vs ARDT Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while ARDT trades at $10.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas ARDT's P/E ratio is 6.66. In terms of profitability, CCEL's ROE is +0.14%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, CCEL is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check ARDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
CCEL vs INNV Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while INNV trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas INNV's P/E ratio is -127.44. In terms of profitability, CCEL's ROE is +0.14%, compared to INNV's ROE of -0.09%. Regarding short-term risk, CCEL is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check INNV's competition here
Agilon Health, Inc. (NYSE: AGL)
CCEL vs AGL Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AGL trades at $92.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AGL's P/E ratio is -9.13. In terms of profitability, CCEL's ROE is +0.14%, compared to AGL's ROE of -1.46%. Regarding short-term risk, CCEL is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AGL's competition here
COMPASS Pathways plc (NASDAQ: CMPS)
CCEL vs CMPS Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, CMPS has a market cap of 1.5B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while CMPS trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas CMPS's P/E ratio is -5.32. In terms of profitability, CCEL's ROE is +0.14%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, CCEL is more volatile compared to CMPS. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check CMPS's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
CCEL vs PNTG Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while PNTG trades at $41.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas PNTG's P/E ratio is 33.40. In terms of profitability, CCEL's ROE is +0.14%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, CCEL is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
CCEL vs AMN Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AMN trades at $34.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AMN's P/E ratio is 11.51. In terms of profitability, CCEL's ROE is +0.14%, compared to AMN's ROE of -0.05%. Regarding short-term risk, CCEL is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
CCEL vs BKDT Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas BKDT's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, CCEL is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
CCEL vs USPH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while USPH trades at $79.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas USPH's P/E ratio is 30.75. In terms of profitability, CCEL's ROE is +0.14%, compared to USPH's ROE of +0.00%. Regarding short-term risk, CCEL is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check USPH's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
CCEL vs NUTX Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, NUTX has a market cap of 966.8M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while NUTX trades at $140.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas NUTX's P/E ratio is 10.86. In terms of profitability, CCEL's ROE is +0.14%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, CCEL is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check NUTX's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
CCEL vs FSHCX Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, FSHCX has a market cap of 906.7M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while FSHCX trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas FSHCX's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to FSHCX's ROE of N/A. Regarding short-term risk, CCEL is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check FSHCX's competition here
Talkspace, Inc. (NASDAQ: TALK)
CCEL vs TALK Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, TALK has a market cap of 874.4M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while TALK trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas TALK's P/E ratio is 769.91. In terms of profitability, CCEL's ROE is +0.14%, compared to TALK's ROE of +0.01%. Regarding short-term risk, CCEL is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check TALK's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
CCEL vs SNDA Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, SNDA has a market cap of 815.1M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while SNDA trades at $40.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas SNDA's P/E ratio is -7.55. In terms of profitability, CCEL's ROE is +0.14%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, CCEL is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check SNDA's competition here
Enhabit, Inc. (NYSE: EHAB)
CCEL vs EHAB Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas EHAB's P/E ratio is -197.14. In terms of profitability, CCEL's ROE is +0.14%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, CCEL is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
CCEL vs GMRS Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, GMRS has a market cap of 593.1M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while GMRS trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas GMRS's P/E ratio is 5.76. In terms of profitability, CCEL's ROE is +0.14%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, CCEL is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
CCEL vs TOIIW Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, TOIIW has a market cap of 490.9M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, CCEL's ROE is +0.14%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, CCEL is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check TOIIW's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
CCEL vs TOI Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, TOI has a market cap of 476.9M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while TOI trades at $4.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas TOI's P/E ratio is -13.25. In terms of profitability, CCEL's ROE is +0.14%, compared to TOI's ROE of +3.27%. Regarding short-term risk, CCEL is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check TOI's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
CCEL vs VMD Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, VMD has a market cap of 446.6M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while VMD trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas VMD's P/E ratio is 31.49. In terms of profitability, CCEL's ROE is +0.14%, compared to VMD's ROE of +0.11%. Regarding short-term risk, CCEL is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check VMD's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
CCEL vs MCTA Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas MCTA's P/E ratio is 419.36. In terms of profitability, CCEL's ROE is +0.14%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, CCEL is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
CCEL vs SRTA Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, SRTA has a market cap of 421.4M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while SRTA trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas SRTA's P/E ratio is -34.26. In terms of profitability, CCEL's ROE is +0.14%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, CCEL is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check SRTA's competition here
Auna S.A. (NYSE: AUNA)
CCEL vs AUNA Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AUNA has a market cap of 384.9M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AUNA trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AUNA's P/E ratio is 4.68. In terms of profitability, CCEL's ROE is +0.14%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, CCEL is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
CCEL vs CYH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, CYH has a market cap of 382.1M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while CYH trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas CYH's P/E ratio is 3.71. In terms of profitability, CCEL's ROE is +0.14%, compared to CYH's ROE of +0.21%. Regarding short-term risk, CCEL is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check CYH's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
CCEL vs AIRS Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AIRS has a market cap of 307.2M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AIRS trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AIRS's P/E ratio is -145.17. In terms of profitability, CCEL's ROE is +0.14%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, CCEL is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
CCEL vs CSU Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas CSU's P/E ratio is 0.67. In terms of profitability, CCEL's ROE is +0.14%, compared to CSU's ROE of -0.51%. Regarding short-term risk, CCEL is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
CCEL vs JYNT Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, JYNT has a market cap of 118.9M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while JYNT trades at $8.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas JYNT's P/E ratio is 83.40. In terms of profitability, CCEL's ROE is +0.14%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, CCEL is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
CCEL vs FVE Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas FVE's P/E ratio is -5.64. In terms of profitability, CCEL's ROE is +0.14%, compared to FVE's ROE of -0.15%. Regarding short-term risk, CCEL is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
CCEL vs KDLYW Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas KDLYW's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, CCEL is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
CCEL vs BTMD Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, BTMD has a market cap of 90M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while BTMD trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas BTMD's P/E ratio is 4.64. In terms of profitability, CCEL's ROE is +0.14%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, CCEL is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check BTMD's competition here
DocGo Inc. (NASDAQ: DCGO)
CCEL vs DCGO Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, DCGO has a market cap of 64.2M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while DCGO trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas DCGO's P/E ratio is -0.75. In terms of profitability, CCEL's ROE is +0.14%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, CCEL is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
CCEL vs ALR Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas ALR's P/E ratio is -1.11. In terms of profitability, CCEL's ROE is +0.14%, compared to ALR's ROE of -0.15%. Regarding short-term risk, CCEL is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check ALR's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
CCEL vs PARK Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, PARK has a market cap of 35M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while PARK trades at $17.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas PARK's P/E ratio is 24.30. In terms of profitability, CCEL's ROE is +0.14%, compared to PARK's ROE of -0.24%. Regarding short-term risk, CCEL is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check PARK's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
CCEL vs PIII Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, PIII has a market cap of 34.8M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while PIII trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas PIII's P/E ratio is -0.27. In terms of profitability, CCEL's ROE is +0.14%, compared to PIII's ROE of +1.85%. Regarding short-term risk, CCEL is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
CCEL vs IMAC Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas IMAC's P/E ratio is -2.27. In terms of profitability, CCEL's ROE is +0.14%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, CCEL is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check IMAC's competition here
Cano Health, Inc. (NYSE: CANO-WT)
CCEL vs CANO-WT Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, CCEL is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
CCEL vs AIH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AIH's P/E ratio is -2.78. In terms of profitability, CCEL's ROE is +0.14%, compared to AIH's ROE of +1.16%. Regarding short-term risk, CCEL is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
CCEL vs CANO Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas CANO's P/E ratio is -0.01. In terms of profitability, CCEL's ROE is +0.14%, compared to CANO's ROE of -1.49%. Regarding short-term risk, CCEL is more volatile compared to CANO. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check CANO's competition here
American Shared Hospital Services (AMEX: AMS)
CCEL vs AMS Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AMS has a market cap of 10.5M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AMS trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AMS's P/E ratio is -7.10. In terms of profitability, CCEL's ROE is +0.14%, compared to AMS's ROE of -0.06%. Regarding short-term risk, CCEL is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AMS's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
CCEL vs FPCG Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas FPCG's P/E ratio is 0.09. In terms of profitability, CCEL's ROE is +0.14%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, CCEL is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
CCEL vs FTRP Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas FTRP's P/E ratio is -1.22. In terms of profitability, CCEL's ROE is +0.14%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, CCEL is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
CCEL vs BMGL Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, BMGL has a market cap of 8.9M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while BMGL trades at $5.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas BMGL's P/E ratio is -1.08. In terms of profitability, CCEL's ROE is +0.14%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, CCEL is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
CCEL vs XWEL Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, XWEL has a market cap of 6.5M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while XWEL trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas XWEL's P/E ratio is -0.32. In terms of profitability, CCEL's ROE is +0.14%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, CCEL is more volatile compared to XWEL. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
CCEL vs MODV Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas MODV's P/E ratio is -0.06. In terms of profitability, CCEL's ROE is +0.14%, compared to MODV's ROE of +1.36%. Regarding short-term risk, CCEL is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
CCEL vs GBNH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas GBNH's P/E ratio is -0.06. In terms of profitability, CCEL's ROE is +0.14%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, CCEL is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
CCEL vs RHE Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas RHE's P/E ratio is -1.79. In terms of profitability, CCEL's ROE is +0.14%, compared to RHE's ROE of -0.36%. Regarding short-term risk, CCEL is more volatile compared to RHE. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
CCEL vs RHE-PA Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, CCEL's ROE is +0.14%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, CCEL is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check RHE-PA's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
CCEL vs AIDX Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AIDX has a market cap of 2.5M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AIDX trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AIDX's P/E ratio is -0.83. In terms of profitability, CCEL's ROE is +0.14%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, CCEL is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
CCEL vs IMACW Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas IMACW's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, CCEL is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
CCEL vs NAKAW Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, CCEL's ROE is +0.14%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, CCEL is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
CCEL vs CCM Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, CCM has a market cap of 642.2K. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while CCM trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas CCM's P/E ratio is -0.30. In terms of profitability, CCEL's ROE is +0.14%, compared to CCM's ROE of +0.06%. Regarding short-term risk, CCEL is more volatile compared to CCM. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
CCEL vs NIVF Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, NIVF has a market cap of 159.8K. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while NIVF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas NIVF's P/E ratio is 0.42. In terms of profitability, CCEL's ROE is +0.14%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, CCEL is more volatile compared to NIVF. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
CCEL vs MNDR Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, MNDR has a market cap of 41.1K. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while MNDR trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas MNDR's P/E ratio is -0.04. In terms of profitability, CCEL's ROE is +0.14%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, CCEL is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
CCEL vs NIVFW Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, NIVFW has a market cap of 39.1K. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, CCEL's ROE is +0.14%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, CCEL is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
CCEL vs TALKW Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas TALKW's P/E ratio is 0.00. In terms of profitability, CCEL's ROE is +0.14%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, CCEL is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check TALKW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
CCEL vs TLMDW Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas TLMDW's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, CCEL is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check TLMDW's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
CCEL vs ATIP-WT Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, CCEL is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check ATIP-WT's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
CCEL vs SLHGP Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, CCEL's ROE is +0.14%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, CCEL is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
CCEL vs SLHG Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas SLHG's P/E ratio is -1.48. In terms of profitability, CCEL's ROE is +0.14%, compared to SLHG's ROE of N/A. Regarding short-term risk, CCEL is more volatile compared to SLHG. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
CCEL vs AFAM Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas AFAM's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, CCEL is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
CCEL vs TLMD Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas TLMD's P/E ratio is -1.60. In terms of profitability, CCEL's ROE is +0.14%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, CCEL is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
CCEL vs KND Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, KND has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas KND's P/E ratio is -1.14. In terms of profitability, CCEL's ROE is +0.14%, compared to KND's ROE of -0.53%. Regarding short-term risk, CCEL is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check KND's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
CCEL vs DVCR Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas DVCR's P/E ratio is 28.34. In terms of profitability, CCEL's ROE is +0.14%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, CCEL is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check DVCR's competition here
Hanger, Inc. (NYSE: HNGR)
CCEL vs HNGR Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas HNGR's P/E ratio is 19.71. In terms of profitability, CCEL's ROE is +0.14%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, CCEL is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check HNGR's competition here
New Frontier Health Corporation (NYSE: NFH)
CCEL vs NFH Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, NFH has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas NFH's P/E ratio is -19.75. In terms of profitability, CCEL's ROE is +0.14%, compared to NFH's ROE of -0.06%. Regarding short-term risk, CCEL is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check NFH's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
CCEL vs TVTY Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas TVTY's P/E ratio is 19.06. In terms of profitability, CCEL's ROE is +0.14%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, CCEL is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check TVTY's competition here
DocGo Inc. (NASDAQ: DCGOW)
CCEL vs DCGOW Comparison July 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 28.2M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, CCEL is priced at $3.37 on the AMEX, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -10.61, whereas DCGOW's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, CCEL is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for CCEL.Check DCGOW's competition here